Cargando…
Medullary Thyroid Cancer – Feature Review and Update on Systemic Treatment
Medullary thyroid carcinoma (MTC) is a rare malignancy that originates from parafollicular (C cells) of the thyroid and accounts for 2-4% of all thyroid malignancies. MTC may be sporadic or inherited, the latter as part of the MEN 2 syndromes. Germline mutations in the RET proto-oncogene (REarranged...
Autores principales: | Dabelić, Nina, Jukić, Tomislav, Fröbe, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212605/ https://www.ncbi.nlm.nih.gov/pubmed/34219884 http://dx.doi.org/10.20471/acc.2020.59.s1.06 |
Ejemplares similares
-
Long-Term Outcome of Differentiated Thyroid Cancer Patients—Fifty Years of Croatian Thyroid Disease Referral Centre Experience
por: Jukić, Tomislav, et al.
Publicado: (2022) -
Medullary Thyroid Cancer: Updates and Challenges
por: Gild, Matti L, et al.
Publicado: (2023) -
DIFFERENTIATED THYROID CANCER IN PEDIATRIC POPULATION (≤18 YEARS): POSTOPERATIVE TREATMENT WITH RADIOACTIVE IODINE (I-131)
por: Prpić, Marin, et al.
Publicado: (2019) -
Medullary Thyroid Carcinoma: An Update on Imaging
por: Kushchayev, Sergiy V., et al.
Publicado: (2019) -
Medullary carcinoma of the thyroid: an update
por: Alevizaki, Maria
Publicado: (2013)